Advances in the relationship between glycosyltransferases and multidrug resistance in cancer
Yinshuang Wu1, Xixi Chen2, Shidan Wang1
1Department of Biochemistry and Molecular Biology, Institute of Glycobiology, Dalian Medical University, Dalian, Liaoning, China.
Abstract:
Despite great progress in clinical treatment, cancer remains a serious health problem contributing to significant morbidity and mortality worldwide. Although chemotherapy is a common therapeutic measure, multidrug resistance (MDR) presents a major challenge that often leads to poor prognosis. The abnormal expression of glycosyltransferases (GTs) leading to aberrant glycosylation patterns are considered a marker of cancer. Furthermore, the biosynthesis of these glycoconjugates has been associated with tumor proliferation, invasion and metastasis. Recently, studies have found that GTs are involved in mediating MDR in cancer cells through complex mechanisms and can influence therapeutic effect. In this review, we focus on several types of cancers and summarize previous studies on the correlation between GTs and MDR.
Insights
Glycosyltransferases (GTs) are linked to cancer progression and multidrug resistance (MDR). Understanding GTs
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Background:
- Cancer remains a significant global health challenge, causing substantial morbidity and mortality.
- Multidrug resistance (MDR) in chemotherapy is a major obstacle to effective cancer treatment.
- Aberrant glycosylation, often due to abnormal glycosyltransferase (GT) expression, is a hallmark of cancer.
Purpose of the Study:
- To review the role of glycosyltransferases (GTs) in mediating multidrug resistance (MDR) in various cancer types.
- To summarize existing research on the correlation between GTs and MDR in cancer cells.
- To explore the complex mechanisms by which GTs influence therapeutic outcomes in cancer treatment.
Main Methods:
- Systematic literature review of studies investigating glycosyltransferases (GTs) and multidrug resistance (MDR).
- Analysis of research focusing on the association between GTs, aberrant glycosylation, and cancer progression.
- Examination of studies detailing the mechanisms of GT involvement in MDR.
Main Results:
- Abnormal expression of GTs is frequently observed in cancer and linked to aberrant glycosylation patterns.
- GTs play a crucial role in the development and maintenance of MDR in cancer cells.
- The activity of GTs can significantly impact the efficacy of chemotherapy and overall therapeutic effect.
Conclusions:
- Glycosyltransferases (GTs) are implicated as key players in cancer multidrug resistance (MDR).
- Targeting GTs may offer novel strategies to overcome MDR and improve cancer treatment outcomes.
- Further research into GTs and their mechanisms in cancer is warranted for therapeutic advancements.
Related Concept Videos
Treatment Resistant Cancers
Relationship Formation
Ending Relationships
Relationship Growth
Social Relationships and Well-Being
Resistivity


